Bayer AG (for the entire manufacturing process)
UkraineAll drugs from this manufacturer
-
The drug is indicated for adults for the prevention of atherothrombotic events following acute coronary syndrome (ACS), as well as for patients with ischemic heart disease or peripheral artery disease with a high risk of ischemic complications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 2.5 mg ATC: B01AF01